Amylin (Human)
- Code:
- 4219-v
- Name:
- Amylin (Human)
-
IAPP: Islet Amyloid Polypeptide
DAP: Diabetes-Associated Peptide
- Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (Disulfide bond between Cys2-Cys7)
- (Trifluoroacetate Form)
- (M.W. 3903.3) C165H261N51O55S2
- main
- more information
- reference
main
- Purity:
- ≧97.0% (HPLC)
- Other Name:
- Diabetes Associated Peptide Amide human
- Islet Amyloid Polypeptide (human)
- Amylin (1 - 37), human, amide
- アミリン
- Storage:
- -20 ℃
- Production:
- Synthetic Product
Solubility: H2O (0.1 mM)
more information
- Category:
- Biologically Active Peptides
reference
- P. Westermark, C. Wernstedt, E. Wilander, D.W. Hayden, T.D. O'Brien, and K.H. Johnson, Proc. Natl. Acad. Sci. USA, 84, 3881 (1987). (Original; 36th A.A. Unknown)
- G.J.S. Cooper, A.C. Willis, A. Clark, R.C. Turner, R.B. Sim, and K.B.M. Reid, Proc. Natl. Acad. Sci. USA, 84, 8628 (1987). (Original; Complete Sequence)
- A. Clark, G.J.S. Cooper, C.E. Lewis, J.F. Morris, A.C. Willis, K.B.M. Reid, and R.C. Turner, Lancet, 2, 231 (1987). (May be Pathogenic)
- G.J.S. Cooper, Endocr. Rev., 15, 163 (1994). (Review)
- J.W.M. Höppener, B. Ahrén, and C.J.M. Lips, N. Engl. J. Med., 343, 411 (2000). (Review)
- S.A. Jayasinghe and R. Langen, Biochim. Biophys. Acta, 1768, 2002 (2007). (Review)
- L. Haataja, T. Gurlo, C.J. Huang, and P.C. Butler, Endocr. Rev., 29, 303 (2008). (Review)
SDS:他の製品を検索する
